SeptiCyte RAPID
Provider 
Founded —
Sells To —
Pricing Model —
Ownership —
Host-response blood test that quantifies sepsis likelihood from immune RNA in about an hour.
SeptiCyte RAPID measures host immune RNA from whole blood on an automated PCR platform and computes a four-band SeptiScore estimating sepsis likelihood for critically ill patients with suspected systemic inflammation.
Hospital laboratories use the score to rule sepsis in or out with high confidence, supported by FDA market clearance as a one-hour direct-from-blood sepsis test.
| Attribute | SeptiCyte RAPID | TriVerity | |
|---|---|---|---|
| Provider | |||
| Founded | — | 2016 | |
| Sells To | — | B2B, Enterprise | |
| Pricing Model | — | Product Sales, Recurring, Software | |
| Ownership | — | Venture-backed |
Provider 
Founded —
Sells To —
Pricing Model —
Ownership —
Provider 
Founded 2016
Sells To B2B, Enterprise
Pricing Model Product Sales, Recurring, Software
Ownership Venture-backed


Rapid host-response blood test that stratifies sepsis risk in emergency departments within about eight minutes.
Rapid host-response blood test that stratifies sepsis risk in emergency departments within about eight minutes.


Host-response blood test distinguishing bacterial from viral infection in fifteen minutes.

Instrument-free fingerstick test separating bacterial from non-bacterial infection in ten minutes.


Point-of-care multiplex PCR platform returning syndromic respiratory results in about fifteen minutes.

Cartridge-based point-of-care PCR system delivering infectious-disease results in under an hour.
Host-response blood test distinguishing bacterial from viral infection in fifteen minutes.
Instrument-free fingerstick test separating bacterial from non-bacterial infection in ten minutes.

Point-of-care multiplex PCR platform returning syndromic respiratory results in about fifteen minutes.

Cartridge-based point-of-care PCR system delivering infectious-disease results in under an hour.
